Skip to the page

Data / Drug companies / Medline Industries, LP

Medline Industries, LP: 115 products in the FDA NDC directory, labeler code 53329

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Medline Industries, LP (labeler code 53329) lists 115 products in the FDA National Drug Code Directory, covering 44 finished drugs by generic name. By type: 114 over the counter drugs, 1 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 28, 2026.

The request: Watch Medline Industries, LP (FDA labeler code 53329): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
53329
Products in commercial distribution
115
Packages
235
Finished drugs by generic name
44
Prescription products
1
Over the counter products
114
Flagged as original packager
103 of 103 products that carry the flag
Started marketing in the last 12 months
17
Products with a marketing end date set
19
Earliest marketing start
April 30, 2002
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs10389.6%
Generic drugs (ANDA)108.7%
New drug applications (NDA)21.7%

Products by type

TypeProductsShare
Over the counter drugs11499.1%
Prescription drugs10.9%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Swab1513%
Cloth1210.4%
Cream119.6%
Ointment97.8%
Solution87%
Tablet76.1%
Liquid76.1%
Gel76.1%
Spray65.2%
Paste65.2%
Patch54.3%
Tablet, coated21.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Medline53329-605TabletOver the counter monograph drugsAugust 28, 2026
Medline53329-603Tablet, film coatedGeneric drugs (ANDA)August 28, 2026
Medline53329-221Tablet, extended releaseGeneric drugs (ANDA)August 28, 2026
Medline53329-199TabletOver the counter monograph drugsAugust 28, 2026
Medline Industries53329-036Tablet, film coatedGeneric drugs (ANDA)August 28, 2026
Medline53329-256OintmentOver the counter monograph drugsAugust 5, 2026
Medline53329-604TabletOver the counter monograph drugsJuly 20, 2026
Medline53329-271CreamOver the counter monograph drugsJuly 1, 2026
Medline53329-600Tablet, delayed releaseOver the counter monograph drugsJune 29, 2026
Medline53329-257OintmentOver the counter monograph drugsJune 24, 2026
Medline53329-255PasteOver the counter monograph drugsJune 15, 2026
Medline53329-251LotionOver the counter monograph drugsJune 9, 2026
Medline53329-259CreamOver the counter monograph drugsJune 8, 2026
Medline53329-234SwabOver the counter monograph drugsApril 16, 2026
Medline53329-230GelOver the counter monograph drugsApril 8, 2026
Medline53329-232SwabOver the counter monograph drugsMarch 30, 2026
Medline53329-233SwabOver the counter monograph drugsMarch 25, 2026
Medline53329-149CreamOver the counter monograph drugsJune 1, 2025
Medline53329-973PatchOver the counter monograph drugsFebruary 1, 2025
Medline53329-972PatchOver the counter monograph drugsFebruary 1, 2025
Medline53329-218CreamOver the counter monograph drugsOctober 1, 2024
Medline53329-125SwabOver the counter monograph drugsSeptember 1, 2024
Medline53329-189OintmentOver the counter monograph drugsAugust 1, 2024
Medline53329-194TabletOver the counter monograph drugsJuly 1, 2024
Medline53329-121SwabOver the counter monograph drugsJuly 1, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.